Type of lung cancer-Small cell lung carcinoma (SCLC) Posts on Medivizor
Navigation Menu

Type of lung cancer-Small cell lung carcinoma (SCLC) Posts on Medivizor

Searching for patients with unresponsive breast cancer to trial an experimental treatment.

Searching for patients with unresponsive breast cancer to trial an experimental treatment.

Posted by on Aug 15, 2021 in Breast cancer | 0 comments

In a nutshell This trial aims to assess the safety and effectiveness of an experimental drug, CYT-0851 in the treatment of B-cell and solid tumors, including breast cancer, that have come back or are no longer responsive to treatments. The main outcomes to be measured are the side effects and the overall response to the treatment....

Read More

Should durvalumab be considered a first-line treatment for extensive small cell lung cancer?

Should durvalumab be considered a first-line treatment for extensive small cell lung cancer?

Posted by on Apr 30, 2021 in Lung cancer | 0 comments

In a nutshell This study looked at the effectiveness of durvalumab (Imfinzi) with or without tremelimumab plus platinum-etoposide (Etopophos) (PE) versus PE-alone for the treatment of extensive-stage small-cell lung cancer (ESCLC). The authors found that durvalumab plus PE showed sustain survival improvement in these patients. Some background...

Read More

Searching for patients with advanced lung cancer to trial a new immune treatment.

Searching for patients with advanced lung cancer to trial a new immune treatment.

Posted by on Nov 8, 2020 in Lung cancer | 0 comments

In a nutshell This trial is looking at the effectiveness, safety, and tolerability of ladiratuzumab vedotin (LV) in patients with advanced solid tumors, including lung cancer. The main outcome to be measured in this trial is the response rate to the new drug. The details Advanced tumors have spread from the organ where they originated. These tumors...

Read More

Treating advanced and reoccurring small cell lung cancer with pembrolizumab

Posted by on Jan 26, 2020 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if pembrolizumab (Keytruda) treatment works in patients with small-cell lung cancer who have received at least two other types of cancer treatment before. The study found that treatment with pembrolizumab was effective and well tolerated in these patients. Some background Small-cell lung cancer (SCLC)...

Read More

Can neutrophil to lymphocyte ratio guide treatment choice in small cell lung cancer?

Posted by on Sep 9, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated if neutrophil to lymphocyte ratio (NLR) can be used to chose a first-line treatment in patients with small-cell lung cancer (SCLC). They found that NLR could be used to choose a treatment for these patients. Some background Lung cancer is a common cancer with poor prognosis. Small cell lung cancer (SCLC) is a...

Read More

Searching for patients with lung cancer to trial a combination of immunotherapy and chemoradiation

Posted by on Jul 24, 2019 in Lung cancer | 0 comments

In a nutshell This trial aims to investigate the safety and effectiveness of durvalumab (Imfinzi) combined with chemotherapy and radiation in patients with advanced lung tumors. The main outcome that will be measured is if there are any side effects and survival without signs of disease. The details Duravalumab is an anti-cancer...

Read More

Search for patients with relapsed or unresponsive small cell lung cancer to try a treatment combination

Posted by on Jun 29, 2019 in Lung cancer | 0 comments

In a nutshell This study wants to find out how well talazoparib (Talzenna) and temozolomide (Temodal) work for treating patients with small cell lung cancer that has come back after or was unresponsive to initial chemotherapy. The main outcome that will be measured is how long the patients go before the cancer grows. The study is...

Read More